Jane Y Tong1, Amanda Wong2, Daniel Zhu2, Judd H Fastenberg2,3, Tristan Tham2,3. 1. Drexel University College of Medicine, Philadelphia, Pennsylvania, USA. 2. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA. 3. Department of Otolaryngology-Head and Neck Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, Hempstead, New York, USA.
Abstract
OBJECTIVE: To determine the pooled global prevalence of olfactory and gustatory dysfunction in patients with the 2019 novel coronavirus (COVID-19). DATA SOURCES: Literature searches of PubMed, Embase, and Scopus were conducted on April 19, 2020, to include articles written in English that reported the prevalence of olfactory or gustatory dysfunction in COVID-19 patients. REVIEW METHODS: Search strategies developed for each database contained keywords such as anosmia, dysgeusia, and COVID-19. Resulting articles were imported into a systematic review software and underwent screening. Data from articles that met inclusion criteria were extracted and analyzed. Meta-analysis using pooled prevalence estimates in a random-effects model were calculated. RESULTS: Ten studies were analyzed for olfactory dysfunction (n = 1627), demonstrating 52.73% (95% CI, 29.64%-75.23%) prevalence among patients with COVID-19. Nine studies were analyzed for gustatory dysfunction (n = 1390), demonstrating 43.93% (95% CI, 20.46%-68.95%) prevalence. Subgroup analyses were conducted for studies evaluating olfactory dysfunction using nonvalidated and validated instruments and demonstrated 36.64% (95% CI, 18.31%-57.24%) and 86.60% (95% CI, 72.95%-95.95%) prevalence, respectively. CONCLUSIONS: Olfactory and gustatory dysfunction are common symptoms in patients with COVID-19 and may represent early symptoms in the clinical course of infection. Increased awareness of this fact may encourage earlier diagnosis and treatment, as well as heighten vigilance for viral transmission. To our knowledge, this is the first meta-analysis to report on the prevalence of these symptoms in COVID-19 patients.
OBJECTIVE: To determine the pooled global prevalence of olfactory and gustatory dysfunction in patients with the 2019 novel coronavirus (COVID-19). DATA SOURCES: Literature searches of PubMed, Embase, and Scopus were conducted on April 19, 2020, to include articles written in English that reported the prevalence of olfactory or gustatory dysfunction in COVID-19patients. REVIEW METHODS: Search strategies developed for each database contained keywords such as anosmia, dysgeusia, and COVID-19. Resulting articles were imported into a systematic review software and underwent screening. Data from articles that met inclusion criteria were extracted and analyzed. Meta-analysis using pooled prevalence estimates in a random-effects model were calculated. RESULTS: Ten studies were analyzed for olfactory dysfunction (n = 1627), demonstrating 52.73% (95% CI, 29.64%-75.23%) prevalence among patients with COVID-19. Nine studies were analyzed for gustatory dysfunction (n = 1390), demonstrating 43.93% (95% CI, 20.46%-68.95%) prevalence. Subgroup analyses were conducted for studies evaluating olfactory dysfunction using nonvalidated and validated instruments and demonstrated 36.64% (95% CI, 18.31%-57.24%) and 86.60% (95% CI, 72.95%-95.95%) prevalence, respectively. CONCLUSIONS: Olfactory and gustatory dysfunction are common symptoms in patients with COVID-19 and may represent early symptoms in the clinical course of infection. Increased awareness of this fact may encourage earlier diagnosis and treatment, as well as heighten vigilance for viral transmission. To our knowledge, this is the first meta-analysis to report on the prevalence of these symptoms in COVID-19patients.
Authors: A Printza; M Katotomichelakis; S Metallidis; P Panagopoulos; A Sarafidou; V Petrakis; J Constantinidis Journal: Hippokratia Date: 2020 Apr-Jun Impact factor: 0.471
Authors: Manuel Krone; Julia Gütling; Johannes Wagener; Thiên-Trí Lâm; Christoph Schoen; Ulrich Vogel; August Stich; Florian Wedekink; Jörg Wischhusen; Thomas Kerkau; Niklas Beyersdorf; Silvana Klingler; Simone Backes; Lars Dölken; Georg Gasteiger; Oliver Kurzai; Alexandra Schubert-Unkmeir Journal: J Clin Microbiol Date: 2021-07-19 Impact factor: 5.948
Authors: Saad Alhumaid; Abbas Al Mutair; Zainab Al Alawi; Khulud Al Salman; Nourah Al Dossary; Ahmed Omar; Mossa Alismail; Ali M Al Ghazal; Mahdi Bu Jubarah; Hanan Al Shaikh; Maher M Al Mahdi; Sarah Y Alsabati; Dayas K Philip; Mohammed Y Alyousef; Abdulsatar H Al Brahim; Maitham S Al Athan; Salamah A Alomran; Hatim S Ahmed; Haifa Al-Shammari; Alyaa Elhazmi; Ali A Rabaan; Jaffar A Al-Tawfiq; Awad Al-Omari Journal: Eur J Med Res Date: 2021-05-24 Impact factor: 2.175
Authors: A Boscutti; G Delvecchio; A Pigoni; G Cereda; V Ciappolino; M Bellani; P Fusar-Poli; P Brambilla Journal: Brain Behav Immun Health Date: 2021-05-18
Authors: Marie-Kathrin Breyer; Robab Breyer-Kohansal; Sylvia Hartl; Michael Kundi; Lukas Weseslindtner; Karin Stiasny; Elisabeth Puchhammer-Stöckl; Andrea Schrott; Manuela Födinger; Michael Binder; Markus Fiedler; Emiel F M Wouters; Otto C Burghuber Journal: Sci Rep Date: 2021-05-12 Impact factor: 4.379